Current Research & Future Challenges

Vaccine development remains challenging because of the highly sophisticated evasion mechanisms of pathogens for which vaccines are not yet available. Recent years have witnessed both successes and failures of novel vaccine design and the strength of iterative approaches is increasingly appreciated. These combine discovery of novel antigens, adjuvants and vectors in the preclinical stage with computational analyses of clinical data to accelerate vaccine design. Reverse and structural vaccinology have revealed novel antigen candidates and molecular immunology has led to the formulation of promising adjuvants. Gene expression profiles and immune parameters in patients, vaccines and healthy controls have formed the basis for bio-signatures that will provide guidelines for future vaccine design.

 

    Related Conference of Current Research & Future Challenges

    August 17-18, 2020

    3rd World Summit on Virology and Infectious Diseases

    Frankfurt, Germany
    October 30-31, 2020

    Immunology and Vaccinations 2020

    Vancouver, Canada

    Current Research & Future Challenges Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in